Ioele Giuseppina, Tavano Lorena, De Luca Michele, Ragno Gaetano, Picci Nevio, Muzzalupo Rita
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.
Int J Pharm. 2015 Oct 15;494(1):490-7. doi: 10.1016/j.ijpharm.2015.08.053. Epub 2015 Aug 22.
Photostability studies were performed on topical formulations containing diclofenac (DC). Niosomal gels were designed as photostabilization systems and ascorbic acid was also added to the new topical formulations because of its antioxidant property. Photodegradation tests were applied on commercial formulations containing DC and novel prepared gels, according to the ICH rules. The experiments were monitored by spectrophotometry and the data processed by multivariate curve resolution analysis to estimate the spectra and concentration profiles of evolved components. Characterization of niosomes was evaluated by size and distribution measurement, morphological analysis and encapsulation efficiency. Permeation experiments were performed across rabbit ear skin up to 24 h. Photodegradation rate of DC was found very fast in commercial formulation, with a residual content of 90% after only 4.38 min under a radiant exposure of 450 W/m(2). Photostability resulted increased significantly when the drug was entrapped in niosomal systems. The best results were obtained by reaching a 10% degradation after 50.00 min of light exposure after incorporation of DC in niosomes in presence of 5% ascorbic acid. Moreover, niosomal gel also influenced the permeation capability of DC by enhancing the transdermal delivery of the drug. The cumulative dose permeated of DC from niosomal gel was about three times that obtained with the commercial gel.
对含有双氯芬酸(DC)的局部用制剂进行了光稳定性研究。设计了脂质体凝胶作为光稳定系统,并且由于其抗氧化特性,还向新的局部用制剂中添加了抗坏血酸。根据国际协调会议(ICH)规则,对含有DC的商业制剂和新制备的凝胶进行了光降解试验。通过分光光度法监测实验,并通过多元曲线分辨分析处理数据,以估计降解产物的光谱和浓度分布。通过大小和分布测量、形态分析和包封效率评估脂质体的特性。进行了长达24小时的兔耳皮肤渗透实验。在商业制剂中发现DC的光降解速率非常快,在450 W/m²的辐射暴露下仅4.38分钟后残留含量为90%。当药物包封在脂质体系统中时,光稳定性显著提高。在含有5%抗坏血酸的情况下将DC包封在脂质体中,光照50.00分钟后降解10%时获得了最佳结果。此外,脂质体凝胶还通过增强药物的透皮递送影响了DC的渗透能力。DC从脂质体凝胶中渗透的累积剂量约为商业凝胶的三倍。